» Articles » PMID: 2293576

Procollagen Expression by Nonparenchymal Rat Liver Cells in Experimental Biliary Fibrosis

Overview
Specialty Gastroenterology
Date 1990 Jan 1
PMID 2293576
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

To localize the cellular sources of the collagens excessively deposited in the liver in the course of secondary biliary fibrosis, we have analyzed by in situ hybridization the distribution of alpha 2(I), alpha 1(III), and alpha 1(IV) procollagen and albumin RNA transcripts in rat livers up to 6 wk following common bile duct ligation and scission. In normal liver, moderate amounts of alpha 2(I) and alpha 1(III) procollagen RNA were found in nonparenchymal cells, while alpha 1(IV) procollagen gene expression was at the threshold of detection. Following bile duct obstruction, increasing amounts of alpha 2(I), alpha 1(III), and alpha 1(IV) procollagen gene transcripts were observed in cells of the expanding portal tracts and in perisinusoidal cells in areas of excessive collagen deposition. Procollagen gene expressing perisinusoidal cells were colocalized with desmin-immunoreactive cells, suggesting that Ito cells and transitional cells were among the collagen-expressing cell types. Only alpha 1(IV) procollagen transcripts were found in epithelial cells of newly formed bile ducts. Neither normal nor fibrotic liver showed any hybridization signal above background over hepatocytes, indicating that hepatocytes are unlikely to be a major source of hepatic collagen.

Citing Articles

Regenerative Potential of Mesenchymal Stem Cells' (MSCs) Secretome for Liver Fibrosis Therapies.

Nazarie Ignat S, Gharbia S, Hermenean A, Dinescu S, Costache M Int J Mol Sci. 2021; 22(24).

PMID: 34948088 PMC: 8705326. DOI: 10.3390/ijms222413292.


Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of studies.

Al-Dhamin Z, Liu L, Li D, Zhang S, Dong S, Nan Y World J Gastroenterol. 2021; 26(47):7444-7469.

PMID: 33384547 PMC: 7754546. DOI: 10.3748/wjg.v26.i47.7444.


Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis.

Thuy L, Hai H, Kawada N Clin Mol Hepatol. 2020; 26(3):280-293.

PMID: 32492766 PMC: 7364355. DOI: 10.3350/cmh.2020.0037.


Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro.

Hsu W, Liao S, Chyan Y, Huang K, Hsu S, Chen Y Int J Mol Sci. 2019; 20(10).

PMID: 31137784 PMC: 6566198. DOI: 10.3390/ijms20102592.


The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats.

Iwasaki J, Afify M, Bleilevens C, Klinge U, Weiskirchen R, Steitz J Int J Mol Sci. 2019; 20(9).

PMID: 31035686 PMC: 6539833. DOI: 10.3390/ijms20092114.